E-LIB Suche - Ergebnisse für: Ciriza, Constanza

1

Gastroesophageal Reflux and Esophageal Motility Disorder Af..:

de Pablo, Alicia ; Alonso, Rodrigo ; Ciriza, Constanza...
Transplantation Proceedings. 53 (2021) 6 - p. 1989-1997 , 2021

Link: https://doi.org/10.1016/..

2

Optimizing the Use of Linaclotide in Patients with Constipa..:

Rey, Enrique ; Mearin, Fermín ; Alcedo, Javier...
Advances in Therapy. 34 (2017) 3 - p. 587-598 , 2017

Link: https://doi.org/10.1007/..

3

Variation at the Angiotensin-Converting Enzyme and Endothel..:

Coto, Eliecer ; Rodrigo, Luis ; Alvarez, Ruth...
Journal of Cardiovascular Pharmacology. 38 (2001) 6 - p. 833-839 , 2001

Link: https://doi.org/10.1097/..

4

Optimizing the Use of Linaclotide in Patients with Constipa..:

Rey, Enrique ; Mearin, Fermín ; Alcedo, Javier...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350198/. , 2017

Link: http://www.ncbi.nlm.nih...

5

Guía de práctica clínica: síndrome del intestino irritable ..:

Mearin, Fermín, 1956- ; Ciriza, Constanza ; Mínguez, Miguel...
Reproducció del document publicat a: https://doi.org/10.17235/reed.2016.4389/2016. , 2016

Link: http://hdl.handle.net/24..

6

Optimizing the use of linaclotide in patients with constipa..:

Rey, Enrique ; Mearin, Fermín ; Alcedo, Javier...
Advances in Therapy. 2017 Mar;34(3):587-98. ,

Link: http://hdl.handle.net/10..

7

Clinical response to linaclotide at week 4 predicts sustain..:

Serrano-Falcón, Blanca ; Delgado Aros, Silvia ; Mearin, Fermín...
Serrano-Falcón B, Delgado-Aros S, Mearin F, Ciriza de Los Ríos C, Serra J, Mínguez M, et al. Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms. Therap Adv Gastroenterol. 2019 Aug 5; 12: 1-14. DOI:10.1177/1756284819857358. ,

Link: http://hdl.handle.net/10..

8

Documento de puesta al día de la Asociación Española de Neu..:

Serra, Jordi ; Aguilar, Ariadna ; Barba, Elizabeth...
Gastroenterología y Hepatología. , 2024

Link: https://doi.org/10.1016/..

9

Development of a core outcome set for therapeutic studies i..:

Ma, Christopher ; Schoepfer, Alain M. ; Dellon, Evan S....
Journal of Allergy and Clinical Immunology. 149 (2022) 2 - p. 659-670 , 2022

Link: https://doi.org/10.1016/..

10

Budesonide orodispersible tablets for induction of remissio..:

Miehlke, Stephan ; Schlag, Christoph ; Lucendo, Alfredo J....
United European Gastroenterology Journal. 10 (2022) 3 - p. 330-343 , 2022

Link: https://doi.org/10.1002/..

11

EoE CONNECT, the European Registry of Clinical, Environment..:

Lucendo, Alfredo J. ; Santander, Cecilio ; Savarino, Edoardo...
Therapeutic Advances in Gastroenterology. 15 (2022) - p. 175628482210742 , 2022

Link: https://doi.org/10.1177/..

12

881: BUDESONIDE ORODISPERSIBLE TABLETS MAINTAIN CLINICAL, H..:

Schlag, Christoph ; Straumann, Alex ; Lucendo, Alfredo...
Gastroenterology. 162 (2022) 7 - p. S-213 , 2022

Link: https://doi.org/10.1016/..

13

Development of a Core Outcome Set for Therapeutic Studies i..:

Ma, Christopher ; Schoepfer, Alain M. ; Safroneeva, Ekaterina...
Gastroenterology. 161 (2021) 3 - p. 748-755 , 2021

Link: https://doi.org/10.1053/..

14

A Summary of the Meetings of the Development of a Core Outc..:

Ma, Christopher ; Schoepfer, Alain M. ; Safroneeva, Ekaterina...
Gastroenterology. 161 (2021) 3 - p. 778-784 , 2021

Link: https://doi.org/10.1053/..

15

Budesonide Orodispersible Tablets Maintain Remission in a R..:

Straumann, Alex ; Lucendo, Alfredo J. ; Miehlke, Stephan...
Gastroenterology. 159 (2020) 5 - p. 1672-1685.e5 , 2020

Link: https://doi.org/10.1053/..